The Reddit thread on r/Supplements with 800 comments comparing magnesium glycinate brands for sleep is still there. The traffic to it is declining quietly, and the customer who would have read it 18 months ago is now asking Gemini, Perplexity or ChatGPT the same question and getting an answer in 12 seconds with three to five branded product recommendations.
That migration is not a small shift in attention. It is a structural change in how wellness customers discover products at the long-tail. The independent wellness brands that grew through the 2020-2024 wave did so by being the answer to a niche question inside a forum thread. The community knew them. The community recommended them. The community's recommendation built the brand.
The community is being routed through an AI agent now. The agent returns the answer in seconds. The agent cites two or three brands. The brands cited compound. The brands not cited do not. Reddit is still there. Reddit is no longer the discovery layer.
For a wellness brand at £500k-£5m, the question is whether the brand appears inside the answer set when customers ask the questions the brand was built to answer. Most operators have not yet checked. The ones that have are quietly restructuring.
Why the AI cites the brands it cites in wellness
The mechanism the AI uses to decide which wellness brands to cite is different from the mechanism it uses in skincare or makeup. The difference is regulatory caution.
Wellness claims sit in a regulatory grey zone. The FDA, EFSA, MHRA and equivalent bodies all maintain restrictions on what supplement and functional wellness brands can claim. The AI models, particularly the major commercial ones, are trained to be cautious about citing brands whose claims are unsubstantiated or overstated. A brand whose website is full of claims that the model's safety training flags as risk-elevated gets quietly downgraded in the answer set. A brand whose website pairs claims with mechanism, evidence and explicit limitations gets cited.
The brands compounding in the AI answer set in 2026 share a pattern. Their product pages do three things the cautious brands' pages do not.
The first thing they do is pair every commercial claim with a specific mechanism explanation. Not "supports sleep" as a standalone phrase, but "magnesium glycinate is the bisglycinate form of magnesium, which crosses the intestinal barrier more readily and binds to GABA receptors implicated in the sleep-onset cascade." The model can verify the mechanism explanation against its training data. The standalone claim it cannot verify. The mechanism-backed claim gets cited. The standalone claim gets filtered.
The second thing they do is link to or reference the underlying evidence. Not "clinically proven" but "this study by Abbasi et al., 2012, randomised controlled trial, n=46, found a mean Pittsburgh Sleep Quality Index improvement of 1.7 points after eight weeks of supplementation at 500mg daily." The customer reads it as credible. The model reads it as citation-worthy.
The third thing they do is explicitly state limitations. Not "improves sleep" but "may improve sleep quality in adults with mild insomnia, evidence less robust for severe insomnia or shift workers." This is the move most brands resist because it feels like undermining the marketing. In an AI-search environment, it is the move that earns trust from the model and the customer simultaneously.
What AI search models actually trust as evidence
Talking to the people building the safety layers of the major commercial AI models, the hierarchy of evidence the systems are trained to weight is reasonably consistent.
At the top are peer-reviewed randomised controlled trials, cited specifically. The model can verify the citation. The model can read the abstract. The model can rank the brand that names the study against the brand that does not.
Below that are systematic reviews, meta-analyses, and citation in major regulatory frameworks (EFSA approved health claims, FDA NDIs, MHRA traditional herbal registrations). All of these the model trusts.
Below that are observational studies and animal studies. The model uses these but with caveats.
At the bottom, ignored or actively flagged, are testimonials, unspecified "clinical studies," ingredient-as-product claim conflation, and traditional-use claims dressed as efficacy claims.
The wellness brands surfacing in AI answers have product pages that operate at the top three levels of that hierarchy. The wellness brands not surfacing have pages that operate at the bottom level. The difference is not the quality of the product. The difference is the quality of the evidence file the brand keeps and the willingness to put that evidence into the customer-facing content.
Why independent wellness brands have a structural opening
The major wellness conglomerates are slow to make the three changes above for the same reason the fragrance conglomerates are slow to rebuild their product copy. The brand reflex says that listing limitations undermines the marketing, citing specific studies introduces compliance complexity, and writing mechanism into customer copy makes the brand feel less premium.
The independent wellness brands built for the post-2020 cohort already speak this way. Their founders are often credentialed, their customer base expects evidence, and their content already operates closer to the top of the evidence hierarchy than the conglomerates. The rebuild for an independent is a sharpening exercise. The rebuild for a conglomerate is a cultural realignment.
This is the rare moment, similar to the fragrance situation, where the structural advantage genuinely sits with the smaller operator. The independents that move now will compound their AI discoverability for the next 24 months while the conglomerates work through internal compliance and brand alignment debates.
The practical move this quarter
For a wellness brand evaluating its posture in 2026, the three-question audit is direct.
First, take your top three SKUs. For each, can a basic text crawl of the PDP extract the mechanism explanation, the specific study citations, and the limitations? If the answer is no, the data layer is incomplete.
Second, for each top SKU, is there an internal evidence file that documents the studies behind the claims, the methodology, the outcomes, and the gaps? Not a marketing summary. An actual evidence document. If the answer is no, the substantiation work is upstream of the AI search work.
Third, take the top five queries your customers actually ask an AI agent in your category. "What should I take for poor sleep that is not melatonin?" "What is the best magnesium for muscle recovery?" "What helps with cortisol if you cannot stop drinking coffee?" Run each prompt in Gemini, Perplexity and ChatGPT. If your brand does not appear, look at the brands that do. Read their product pages. The pattern will be visible within an hour.
The window to do this work before the conglomerates catch up is approximately six months. The brands that move now compound their share of the answer set. The brands that wait until 2027 will be trying to displace incumbents who have already earned the model's trust.
The wellness brand that wins the AI search era will not be the brand with the loudest marketing. It will be the brand whose product page reads like a clinical study. The customer reads it once and trusts it. The model reads it every time and cites it.